Patents Assigned to ZAFENA AB
  • Patent number: 10613104
    Abstract: An assay to determine anticoagulants in a blood or blood plasma sample, wherein the assay comprises analyses with at least two wet chemistry prothrombine time (PT) methods. The assay comprises measuring PT in a first reaction mixture with a first PT method and measuring PT in a second reaction mixture with a second PT method, wherein the concentration of blood or blood plasma in the second reaction mixture differs from the concentration of blood or blood plasma in the first reaction mixture. The PT methods are calibrated to give the same or approximately the same PT results for reference samples which lack anticoagulants of interest for the assay. Further, calculating a difference in PT from the measurements, wherein if the difference in PT is 1) significant, this is indicative of a presence of anticoagulants in the sample, or 2) non-significant, this is indicative of an absence of anti-coagulants above detectable level in the sample.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: April 7, 2020
    Assignee: ZAFENA AB
    Inventor: Mats Ranby
  • Patent number: 9665692
    Abstract: A system for enabling test data resulting from an analytic determination carried out on a clinical analytic device (20-1) to be communicated to an electronic patient information management system (80), the system comprising: a computer module (120-1) communicatively connectable to the clinical analytic device (20-1), a user operable control unit (140) communicatively connectable to the computer module (120-1), and an instrument tag (22-1) readable by the user operable control unit (140) and associated with the clinical analytic device (20-1).
    Type: Grant
    Filed: August 25, 2011
    Date of Patent: May 30, 2017
    Assignee: Zafena AB
    Inventors: Mats Rånby, Xerxes Rånby
  • Publication number: 20130241707
    Abstract: A system for enabling test data resulting from an analytic determination carried out on a clinical analytic device (20-1) to be communicated to an electronic patient information management system (80), the system comprising: a computer module (120-1) communicatively connectable to the clinical analytic device (20-1), a user operable control unit (140) communicatively connectable to the computer module (120-1), and an instrument tag (22-1) readable by the user operable control unit (140) and associated with the clinical analytic device (20-1).
    Type: Application
    Filed: August 25, 2011
    Publication date: September 19, 2013
    Applicant: ZAFENA AB
    Inventors: Mats Ranby, Xerxes Ranby
  • Patent number: D699837
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: February 18, 2014
    Assignee: Zafena AB
    Inventor: Stefan Ericsson